News & Events

Read the latest, meet us in person.

Separator
Press Inquiries

For press inquiries, please contact us at press@​inscripta.​com

Most recent news

Scaling up CRISPR-based genome engineering in microbes to accelerate biological discovery
Ahead of our upcoming webinar, CRISPR-based multiplexed genome editing for improved heterologous protein engineering and expression in E. coli,” we…
Read More
Population bottlenecks strongly affect the evolutionary dynamics of antibiotic persistence
Bacterial persistence is a potential cause of antibiotic therapy failure. Antibiotic-tolerant persisters originate from phenotypic differentiation…
Read More
The World's First Fully Automated Benchtop Digital Genome Engineering Platform Is Here
As synthetic biology continues to grow, advanced benchtop systems are becoming available to make research and product development easier. Now,…
Read More

Events

Improving heterologous protein production in yeast with massively parallel CRISPR genome editing
August 25, 2021, Webinar
Heterologous protein production is an indispensable tool in biotechnology and biopharma for manufacturing enzymes, protein therapeutics, and more.
Learn More And Register
Population bottlenecks strongly affect the evolutionary dynamics of antibiotic persistence
July 28, 2021, Webinar
Bacterial persistence is a potential cause of antibiotic therapy failure. Recent studies have shown that persistence is a highly evolvable trait,…
Learn More And Register
CRISPR-based multiplexed genome editing for improved heterologous protein engineering and expression in E. coli
June 14, 2021, Webinar
During this webinar, discover how Inscripta experts generated an Escherichia coli saturation mutagenesis library against an integrated green…
Learn More And Register